Predictors of premature termination of cardiac surgery trials: insights from the Clinicaltrial.gov database
Slow recruitment is the most common reason for premature termination of cardiac surgery trials. Trials on left ventricular assist device, valve surgery, aortic surgery, phase 2 trials and phase 4 trials are more likely to be terminated, while trials conducted in Asia and Europe are less likely to be terminated prematurely.
Authors
- Gianmarco Cancelli (ORCID: https://orcid.org/0000-0002-3553-4585)
- Arnaldo Dimagli (ORCID: https://orcid.org/0000-0003-0055-8656)
- Mohamed Rahouma (ORCID: https://orcid.org/0000-0002-8678-2060)
- Giovanni Soletti (ORCID: https://orcid.org/0000-0002-8691-5951)
- Giorgia Falco
- Mudathir Ibrahim (ORCID: https://orcid.org/0000-0002-6345-1533)
- Lamia Harik (ORCID: https://orcid.org/0000-0003-1500-1308)
- Michele Dell'Aquila
- Jordan Leith
- Aina Hirofuji
- Polina Mantaj
- Mario Gaudino (ORCID: https://orcid.org/0000-0003-4680-0815)
- Busra Cangut (ORCID: https://orcid.org/0000-0001-6499-2123)
- Camilla Sofia Rossi (ORCID: https://orcid.org/0009-0002-1379-4615)
- Talal Al Zaghari
Institutions
- Maimonides Medical Center (US)
- Cornell University (US)
- Mount Sinai Hospital (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1093/ejcts/ezae310
- Citations
- 4
- Primary Topic
- Meta-analysis and systematic reviews
- Type
- article
- Field-Weighted Citation Impact
- 1.85